SAMHSA Spotlight on MATx Webinar

Sponsored by the American Society of Addiction Medicine (ASAM), the Substance Abuse and Mental Health Services Administration's (SAMHSA), Spotlight on MATx webinar will discuss medication-assisted treatment (MAT) for opioid use disorder and resources to support health care practitioners who currently provide MAT or plan to do so in the future. Participants will be guided through a step-by-step overview of the Drug Addiction Treatment Act of 2000 (DATA 2000) waiver process, learn how naloxone can be used to reverse the effects of opioid overdose, and discuss current efforts to address the opioid crisis in America. SAMHSA will also unveil MATx, a new mobile app that empowers practitioners to provide effective, evidence-based care

  • Primary care providers and internal medicine specialists
  • Addiction medicine specialists
  • Opioid treatment program providers
  • DATA-waived practitioners
  • Practitioners interested in becoming DATA-waived or learning more about the process
  • National stakeholders (government and nongovernmental organizations)
  • White House Opioid Task Force Committee and their constituents
  • Consumer advocacy organizations
  • Academic institutions

Upon completion of this webinar, participants will:

  1. Understand the evidence base and benefits of MAT for opioid use disorder.
  2. Discuss how the DATA 2000 can support a clinician using the MAT approach for opioid use disorder.
  3. Summarize the DATA 2000 waiver process and explore resources to support clinicians in becoming DATA-waived, increasing patient limits, and updating their information.
  4. Understand how naloxone and MAT programs can help prevent and treat opioid overdose.
  5. Explore features of SAMHSA's MATx mobile app that support practitioners who are actively engaged in MAT for opioid use disorder.
  6. Identify at least two resources available to support the continued use and integration of MAT into their practice.

CME Information and Disclosure Listing

Date of Release: October 21, 2016
Approved Through: October 21, 2018

The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Addiction Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits. Physicians should claim only credit commensurate with the extent of their participation in the activity.

In accordance with the disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all educational activities. These policies include resolving all conflicts of interest between the CME Committee, Planning Committee and faculty, and commercial interests that might otherwise compromise the goal and educational integrity of this activity. All CME Committee, Planning Committee and faculty participating in the activity have disclosed all relevant financial relationships with commercial interests. The CME Committee has reviewed these disclosures and determined that the planning committee and faculty relationships are not inappropriate in the content of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

ASAM CME Committee

Name

Nature of Relevant Financial Relationship

Commercial Interest

What was received?

For what role?

Adam J. Gordon, MD, MPH, FACP, FASAM, Chair

None

Edwin A. Salsitz, MD, FASAM

None

Herbert Malinoff, MD, FACP, FASAM

None



Noel Ilogu, MD, MRCP

None

Abigail Kay, MD

None

John Tanner, DO, FASAM

Reckitt Benckiser

OREXO

BDSI

Honorarium

Honorarium

Honorarium

Speaker

Speaker

Speaker and Consultant

Catherine Friedman, MD

None

SAMHSA Spotlight on MATx Planning Committee

Name

Nature of Relevant Financial Relationship

Commercial Interest

What was received?

For what role?

Alejandra Brackett

None

Robert T. Carroll, PhD(c), RN, MN, ACRN

None


Lisa H. Falconer, MPH, CHES

Cynapsus

Stipend to spouseParticipation in board meeting

Kaitlin A. White, BS

None


SAMHSA Spotlight on MATx Faculty

Name

Nature of Relevant Financial Relationship

Commercial Interest

What was received?

For what role?

Mitra Ahadpour, MD, DABAM

None

Anita Everett, MDNone
Sharon Stancliff, MDNone
R. Corey Waller, MD, MS, DFASAMNone

ASAM CME Committee Reviewers

Name

Nature of Relevant Financial Relationship

Commercial Interest

What was received?

For what role?

Adam J. Gordon, MD, MPH, FACP, FASAM

None

Mitra Ahadpour, MD, DABAM

Director, Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, SAMHSA

Dr. Mitra Ahadpour, MD, DABAM, is a licensed primary care physician, board certified in Addiction Medicine, with over 10 years of providing medical care in Maryland. She is a Medical Officer in the Division of Pharmacologic Therapies at the Substance Abuse and Mental Health Services Administration. During Dr. Ahadpour's tenure at the National Institutes of Health, she developed strategic plans, policies and goals to eliminate health disparities. Clinical intervention points across the lifespan were identified to reduce substance use and detect mental illness in the health disparate population, and evidence-based guidelines were assessed to improve preventive health services. In private practice, she contributed to legislation making Maryland smoke-free and, as chair of Montgomery County Medical Society's Community Service Programs, created and launched a tobacco awareness in middle schools. She attained her MD from the University of Maryland School of Medicine. Her primary care residency was completed at the George Washington University Hospital.

Anita Everett, MD

Chief Medical Officer

SAMHSA recently hired Anita Everett, M.D., to serve as the new chief medical officer. Dr. Everett will lead a staff of five in SAMHSA's new Office of the Chief Medical Officer (OCMO) where they will focus on expanding effective, innovative, and science-supported approaches to behavioral health.

Dr. Everett is currently the division director of Johns Hopkins Community and General Psychiatry, Bayview Campus, in Baltimore, and associate professor at the Department of Psychiatry and Behavioral Health Sciences at Johns Hopkins School of Medicine. Earlier this year she was selected as president-elect for the American Psychiatric Association (APA). She also was past president for both the Maryland Psychiatric Society and the American Association of Community Psychiatrists.

Dr. Everett previously worked with SAMHSA as senior medical advisor where she worked on projects centered on the promotion of access to quality services and appropriate medications. She will begin her new role at SAMHSA on September 5.

Sharon Stancliff

MD, FAAFP

Sharon Stancliff, M.D. is the Medical Director of the Harm Reduction Coalition She oversees SKOOP, which provides overdose prevention services both directly in New York City and through education and capacity building nationally and internationally. Dr. Stancliff also consults on drug related problems for the AIDS Institute, New York State Department of Health and for several international organizations. 

Dr. Stancliff graduated from the School of Medicine at University of California at Davis, did her Family Practice residency at the University of Arizona and completed the AIDS Institute-sponsored Nicolas Rango HIV Clinical Scholars Program at Beth Israel Medical Center in New York City. She is board certified in Family Medicine, a Fellow of the American Academy of Family Practice, and certified by the American Board of Addiction Medicine. She serves as secretary for the New York Society of Addiction Medicine.

R. Corey Waller

MD, MS, DFASAM

R. Corey Waller, MD, MS, FACEP, DFASAM, is an addiction, pain and emergency medicine specialist. Dr. Waller earned his bachelor's degree in biology and his master's degree in neuromolecular biology at Southwest Texas State University in San Marcos, Texas. He earned his medical degree at University of Texas Medical School in San Antonio. Dr. Waller completed his emergency medicine residency at Thomas Jefferson University in Philadelphia. He is board certified and fellowship trained in addiction medicine.

Key:

Complete
Failed
Available
Locked
Webinar Recording
Open to view video.
Open to view video. This webinar was recorded on October 21, 2016.
Quiz
6 Questions
6 Questions CME Quiz
Evaluation
13 Questions
13 Questions Annual Conference 2016 CME Evaluation
CME Certificate
Up to 1.00 medical credits available  |  Certificate available
Up to 1.00 medical credits available  |  Certificate available CME Certificate